Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma-Reference-Cited by-同舟云学术

Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma

Published:2020-04 Issue:4 Volume:26 Page:691-697
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Fasslrinner Frederick^ORCID,Stölzel Friedrich,Kramer Michael,Teipel Raphael,Brogsitter Claudia,Morgner Anke,Arndt Claudia,Bachmann Michael,Hänel Mathias,Röllig Christoph,Kotzerke Jörg,Schetelig Johannes,Bornhäuser Martin

Funder

Else Kröner-Fresenius-Stiftung

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Is there still a role for stem cell transplantation in multiple myeloma?;Mina;Cancer,2019

2. Graft-versus-myeloma effect: proof of principle;Tricot;Blood,1996

3. Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting;Rotta;Blood,2009

4. Reduced-intensity allogeneic transplantation for myeloma: reality bites;Stewart;Blood,2009

5. Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma;Schmidt-Hieber;Bone Marrow Transplant,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years;Frontiers in Oncology;2024-07-31

2. Allogeneic stem cell transplantation in multiple myeloma: is there still a place?;Frontiers in Oncology;2024-06-04

3. Optimization of Radiolabeling of a [90Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation;Cancers;2023-07-18

4. Future Developments in the Treatment of AL Amyloidosis;Hemato;2022-02-07

5. Radionuclide Therapy of Leukemias and Multiple Myeloma;Nuclear Oncology;2022